These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 33889251)
1. Breast cancer molecular subtypes and receptor status among women at Potchefstroom Hospital: a cross-sectional study. Kakudji BK; Mwila PK; Burger JR; du Plessis JM; Naidu K Pan Afr Med J; 2021; 38():85. PubMed ID: 33889251 [TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery. Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768 [TBL] [Abstract][Full Text] [Related]
3. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study. Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840 [TBL] [Abstract][Full Text] [Related]
4. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer. Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women. Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A Breast J; 2013; 19(1):22-30. PubMed ID: 23240985 [TBL] [Abstract][Full Text] [Related]
6. The Association between Molecular Subtypes of Breast Cancer with Histological Grade and Lymph Node Metastases in Indonesian Woman. Setyawati Y; Rahmawati Y; Widodo I; Ghozali A; Purnomosari D Asian Pac J Cancer Prev; 2018 May; 19(5):1263-1268. PubMed ID: 29801411 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Merajver SD; Karlsson C; Karlsson MG BMC Womens Health; 2018 Feb; 18(1):40. PubMed ID: 29444670 [TBL] [Abstract][Full Text] [Related]
8. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil. Carvalho FM; Bacchi LM; Pincerato KM; Van de Rijn M; Bacchi CE BMC Womens Health; 2014 Aug; 14():102. PubMed ID: 25174527 [TBL] [Abstract][Full Text] [Related]
9. Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes. Maisonneuve P; Disalvatore D; Rotmensz N; Curigliano G; Colleoni M; Dellapasqua S; Pruneri G; Mastropasqua MG; Luini A; Bassi F; Pagani G; Viale G; Goldhirsch A Breast Cancer Res; 2014 Jun; 16(3):R65. PubMed ID: 24951027 [TBL] [Abstract][Full Text] [Related]
10. MYC amplification in subtypes of breast cancers in African American women. Naab TJ; Gautam A; Ricks-Santi L; Esnakula AK; Kanaan YM; DeWitty RL; Asgedom G; Makambi KH; Abawi M; Blancato JK BMC Cancer; 2018 Mar; 18(1):274. PubMed ID: 29523126 [TBL] [Abstract][Full Text] [Related]
11. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079 [TBL] [Abstract][Full Text] [Related]
12. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721 [TBL] [Abstract][Full Text] [Related]
13. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013. Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M; Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648 [TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Molecular Subtypes Defined by ER/PR and HER2 Status: Association with Clinicopathologic Parameters in Ivorian Patients. Effi AB; Aman NA; Koui BS; Koffi KD; Traore ZC; Kouyate M Asian Pac J Cancer Prev; 2016; 17(4):1973-8. PubMed ID: 27221883 [TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry. Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW Breast; 2012 Feb; 21(1):50-7. PubMed ID: 21865043 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index. Ono M; Tsuda H; Yoshida M; Shimizu C; Kinoshita T; Tamura K Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822 [TBL] [Abstract][Full Text] [Related]
17. Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening. Caldarella A; Puliti D; Crocetti E; Bianchi S; Vezzosi V; Apicella P; Biancalani M; Giannini A; Urso C; Zolfanelli F; Paci E J Cancer Res Clin Oncol; 2013 Feb; 139(2):181-5. PubMed ID: 22961208 [TBL] [Abstract][Full Text] [Related]
18. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type. Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer. Munzone E; Botteri E; Sandri MT; Esposito A; Adamoli L; Zorzino L; Sciandivasci A; Cassatella MC; Rotmensz N; Aurilio G; Curigliano G; Goldhirsch A; Nolè F Clin Breast Cancer; 2012 Oct; 12(5):340-6. PubMed ID: 23040002 [TBL] [Abstract][Full Text] [Related]
20. Correlation of B-cell lymphoma 2 immunoexpression in invasive carcinoma of breast, no special type with hormone receptor status, proliferation index, and molecular subtypes. Azmat H; Faridi J; Habib HM; Bugti UJ; Sheikh AK; Riaz SK J Cancer Res Ther; 2022 Dec; 18(Supplement):S313-S319. PubMed ID: 36510982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]